The TALLYHO mouse as a model of human type 2 diabetes

Methods in Molecular Biology

Volumn 933, Issue , 2012, Pages 75-87

  Kim, Jung Han ^a   Saxton, Arnold M ^b  

^a MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TENNESSEE   (United States)

Author keywords

Congenics; Glucose intolerance; Hyperglycemia; Hyperlipidemia; Insulin resistance; Islet degranulation; Mice; Obesity; QTL; TALLYHO

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE MEASUREMENT; BONE DENSITY; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; GENETIC SUSCEPTIBILITY; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PRIORITY JOURNAL;

EID: 84934444357     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-68-7_6     Document Type: Article

References (48)

1. Gavin JR 3rd, Stolar MW, Freeman JS et al (2010) Improving outcomes in patients with type 2 diabetes mellitus: practical solutions for clinical challenges. J Am Osteopath Assoc 110:S2-S14
2. Belkina AC, Denis GV (2010) Obesity genes and insulin resistance. Curr Opin Endocrinol Diabetes Obes 17:472-477
3. Elbein SC (2009) Genetics factors contributing to type 2 diabetes across ethnicities. J Diabetes Sci Technol 3:685-689
4. Freeman H, Cox RD (2006) Type-2 diabetes: a cocktail of genetic discovery. Hum Mol Genet 15:R202-R209
5. Surampudi PN, John-Kalarickal J, Fonseca VA (2009) Emerging concepts in the pathophysiology of type 2 diabetes mellitus. Mt Sinai J Med 76:216-226
6. Israili ZH (2011) Advances in the treatment of type 2 diabetes mellitus. Am J Ther 18: 117-152
7. Kim JH, Sen S, Avery CS et al (2001) Genetic analysis of a new mouse model for non-insulindependent diabetes. Genomics 74:273-286
8. Cheng ZJ, Jiang YF, Ding H et al (2007) Vascular dysfunction in type 2 diabetic TallyHo mice: role for an increase in the contribution of PGH2/TxA2 receptor activation and cytochrome p450 products. Can J Physiol Pharmacol 85:404-412
9. Sung YY, Lee YS, Jung WH et al (2005) Glucose intolerance in young TallyHo mice is induced by leptin-mediated inhibition of insulin secretion. Biochem Biophys Res Commun 338:1779-1787
10. Rhee SD, Sung YY, Lee YS et al (2011) Obesity of TallyHO/JngJ mouse is due to increased food intake with early development of leptin resistance. Exp Clin Endocrinol Diabetes 119:243-251
11. Leiter EH (2009) Selecting the "right" mouse model for metabolic syndrome and type 2 diabetes research. Methods Mol Biol 560:1-17
12. Kim JH, Stewart TP, Soltani-Bejnood M et al (2006) Phenotypic characterization of polygenic type 2 diabetes in TALLYHO/JngJ mice. J Endocrinol 191:437-446
13. Leiter EH, Reifsnyder PC (2004) Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes. Diabetes 53:S4-S11
14. Abdul-Ghani MA, DeFronzo RA (2009) Plasma glucose concentration and prediction of future risk of type 2 diabetes. Diabetes Care 32:S194-S198
15. Wang Y, Nishina PM, Naggert JK (2009) Degradation of IRS1 leads to impaired glucose uptake in adipose tissue of the type 2 diabetes mouse model TALLYHO/Jng. J Endocrinol 203:65-74
16. Ostenson CG (2001) The pathophysiology of type 2 diabetes mellitus: an overview. Acta Physiol Scand 171:241-247
17. Myers MG Jr, Leibel RL, Seeley RJ et al (2010) Obesity and leptin resistance: distinguishing cause from effect. Trends Endocrinol Metab 21:643-651
18. Ambati S, Kim HK, Yang JY et al (2007) Effects of leptin on apoptosis and adipogenesis in 3T3- L1 adipocytes. Biochem Pharmacol 73:378-384
19. Won HY, Lee JA, Park ZS et al (2011) Prominent Bone Loss Mediated by RANKL and IL-17 Produced by CD4+T Cells in TallyHo/JngJ Mice. PLoS One 6:e18168
20. Kim KY, Kim JY, Sung YY et al (2011) Inhibitory effect of leptin on rosiglitazoneinduced differentiation of primary adipocytes prepared from TallyHO/Jng mice. Biochem Biophys Res Commun 406:584-589
21. von Eckardstein A, Sibler RA (2011) Possible contributions of lipoproteins and cholesterol to the pathogenesis of diabetes mellitus type 2. Curr Opin Lipidol 22:26-32
22. Singh S, Dhingra S, Ramdath DD et al (2010) Risk factors preceding type 2 diabetes and cardiomyopathy. J Cardiovasc Transl Res 3:580-596
23. Tomkin GH (2008) Targets for intervention in dyslipidemia in diabetes. Diabetes Care 31: S241-S248
24. Schalkwijk CG, Stehouwer CD (2005) Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 109:143-159
25. Didion SP, Lynch CM, Faraci FM (2007) Cerebral vascular dysfunction in TallyHo mice: a new model of Type II diabetes. Am J Physiol Heart Circ Physiol 292:H1579-H1583
26. Glandt M, Bloomgarden ZT (2011) Hypertension in diabetes: treatment considerations. J Clin Hypertens (Greenwich) 13:314-318
27. Merlotti D, Gennari L, Dotta F et al (2010) Mechanisms of impaired bone strength in type 1 and 2 diabetes. Nutr Metab Cardiovasc Dis 20:683-690
28. Yaturu S (2009) Diabetes and skeletal health. J Diabetes 1:246-254
29. Stewart TP, Kim HY, Saxton AM et al (2010) Genetic and genomic analysis of hyperlipidemia, obesity and diabetes using (C57BL/6 J × TALLYHO/JngJ) F2 mice. BMC Genomics 11:713
30. Schmidt C, Gonzaludo NP, Strunk S et al (2008) A meta-analysis of QTL for diabetesrelated traits in rodents. Physiol Genomics 34:42-53
31. Grarup N, Sparso T, Hansen T (2010) Physiologic characterization of type 2 diabetesrelated loci. Curr Diab Rep 10:485-497
32. Clee SM, Attie AD (2007) The genetic landscape of type 2 diabetes in mice. Endocr Rev 28:48-83
33. Goodarzi MO, Lehman DM, Taylor KD et al (2007) SORCS1: a novel human type 2 diabetes susceptibility gene suggested by the mouse. Diabetes 56:1922-1929
34. Scherneck S, Nestler M, Vogel H et al (2009) Positional cloning of zinc finger domain transcription factor Zfp69, a candidate gene for obesity-associated diabetes contributed by mouse locus Nidd/SJL. PLoS Genet 5:e1000541
35. Joost HG (2010) The genetic basis of obesity and type 2 diabetes: lessons from the New Zealand obese mouse, a polygenic model of the metabolic syndrome. Results Probl Cell Differ 52:1-11
36. Rollins J, Chen Y, Paigen B et al (2006) In search of new targets for plasma high-density lipoprotein cholesterol levels: promise of human-mouse comparative genomics. Trends Cardiovasc Med 16:220-234
37. Wang X, Korstanje R, Higgins D et al (2004) Haplotype analysis in multiple crosses to identify a QTL gene. Genome Res 14:1767-1772
38. Kitagawa K, Wang J, Mastushita T et al (2003) Polymorphisms of mouse apolipoprotein A-II: seven alleles found among 41 inbred strains of mice. Amyloid 10:207-214
39. Wang X, Paigen B (2005) Genome-wide search for new genes controlling plasma lipid concentrations in mice and humans. Curr Opin Lipidol 16:127-137
40. Wuschke S, Dahm S, Schmidt C et al (2007) A meta-analysis of quantitative trait loci associated with body weight and adiposity in mice. Int J Obes (Lond) 31(5):829-841
41. Herrera BM, Lindgren CM (2010) The genetics of obesity. Curr Diab Rep 10:498-505
42. Kim JH, Stewart TP, Zhang W et al (2005) Type 2 diabetes mouse model TallyHo carries an obesity gene on chromosome 6 that exaggerates dietary obesity. Physiol Genomics 22:171-181
43. Corva PM, Horvat S, Medrano JF (2001) Quantitative trait loci affecting growth in high growth (hg) mice. Mamm Genome 12:284-290
44. Todd JA (1999) From genome to aetiology in a multifactorial disease, type 1 diabetes. Bioessays 21:164-174
45. Clee SM, Yandell BS, Schueler KM et al (2006) Positional cloning of Sorcs1, a type 2 diabetes quantitative trait locus. Nat Genet 38:688-693
46. Chiu S, Kim K, Haus KA et al (2007) Identification of positional candidate genes for body weight and adiposity in subcongenic mice. Physiol Genomics 31:75-85
47. Dokmanovic-Chouinard M, Chung WK, Chevre JC et al (2008) Positional cloning of "Lisch-Like", a candidate modifier of susceptibility to type 2 diabetes in mice. PLoS Genet 4:e1000137
48. Kim HY, Stewart TP, Wyatt BN et al (2010) Gene expression profiles of a mouse congenic strain carrying an obesity susceptibility QTL under obesigenic diets. Genes Nutr 5: 237-250